Investing.com - Tandem Diabetes Care reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Tandem Diabetes Care announced earnings per share of $-0.76 on revenue of $204.55M. Analysts polled by Investing.com anticipated EPS of $-0.05 on revenue of $207.56M.
Tandem Diabetes Care shares are up 17.79% from the beginning of the year and are trading at $39.60 , down-from-52-week-high.
Tandem Diabetes Care shares lost 22.87% in after-hours trade after the report.
Tandem Diabetes Care follows other major Healthcare sector earnings this month
Tandem Diabetes Care's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar